[The information in this preliminary prospectus supplement is notmplete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are not an offer to sell these securities, nor are they soliciting offers to buy these securities, in any jurisdiction where the offer orle is not permitted. SUBJECT TOMPLETION,TED NOVEMBER 4, 2010]
[Silicon Motion Announces Third Quarter Results for Third Quarter 2010 Financial Highlights Net sales increased 5% quarter-over-quarter to US$34.2 million from US$32.5 million in 2Q10 Gross margin excluding stock-based compensation increased to 48.4% from 47.7% in 2Q10 Operating expenses excluding stock-based compensation, acquisition-related charges, and other items increased to US$13.2 million from US$13.0 million in 2Q10 ] [Press Release issued by the Company on November 4, 2010. ILICON OTION ECHNOLOGY ORPORATION S]
[Chinard Bloodrporation Announces Proposed Public Offering of Ordinary Shares HONG KONG, China, November 4, 2010 - Chinard Bloodrporation (NYSE:) (CCBC or thempany), the first and largestrd blood bank operator in China, today announced that it intends to offer and sell its ordinary shares in an underwritten offering. Jefferies &mpany, is the sole bookrunner for the]
[FORM 10-Q x For the quarterly period ended September 30, 2010 OR o For the transition period from SYNUTRA INTERNATIONAL, INC. DELAWARE 13-4306188 (State or Other Jurisdiction of Incorporation or Organization) I.R.S. Employer Identification No. 2275 Research Blvd., Suite 500 Rockville, Maryland 20850 (301) 840-3888 x o o o o Large accelerated filer x Accelerated filer o Non-accelerated filer o] [I, Liang Zhang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Synutra International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [I, Donghao Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Synutra International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002]
[Chinard Bloodrporation Announces Proposed Public Offering of Ordinary Shares HONG KONG, China, November 4, 2010 - Chinard Bloodrporation (NYSE:) (CCBC or thempany), the first and largestrd blood bank operator in China, today announced that it intends to offer and sell its ordinary shares in an underwritten offering. Jefferies &mpany, is the sole bookrunner for the]
[FORM 10-Q x For the quarterly period ended September 30, 2010 OR o For the transition period from SYNUTRA INTERNATIONAL, INC. DELAWARE 13-4306188 (State or Other Jurisdiction of Incorporation or Organization) I.R.S. Employer Identification No. 2275 Research Blvd., Suite 500 Rockville, Maryland 20850 (301) 840-3888 x o o o o Large accelerated filer x Accelerated filer o Non-accelerated filer o] [I, Liang Zhang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Synutra International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [I, Donghao Yang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Synutra International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002]
[Subject tompletion Preliminary Prospectus STYLE="font-family:Times New Roman" SIZE="2"LOR="#cc062a"> PROSPECTUS 8,400,000 American Depositary Shares STYLE="font-family:Times New Roman" SIZE="5"> NOAHS LIMITED Representing 4,200,000 Ordinary Shares This is the initial public offering of American depositary shares, orSs, of Noahs Limited. We are selling 8,400,000Ss. TwoSs represent one ordinary share, par value $0.0005 per share. We have granted the] [NOAHS LIMITED STYLE="font-family:Times New Roman" SIZE="2">8,400,000 American Depositary Shares Representing 4,200,000 Ordinary Shares, par value $0.0005 per share FORM OF UNDERWRITINGREEMENT November [ STYLE="font-family:Times New Roman" SIZE="2">J.P. MORGAN SECURITIES 383 Madison Avenue New York, New York 10179 U.S.A. and MERRILL LYNCH, PIERCE, FENNER& SMITHORPORATED One Bryant Park] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM STYLE="font-family:Times New Roman" SIZE="2">Wensent to the use in this Registration Statement on Form F-1 of our reportted July26, 2010 relating to the financial statements and financial statementhedule of Noahs Limited appearing in the Prospectus, which is part of this Registration Statement.]
[Synutra Reports Second Quarter and First Half Fiscal 2011 Financial Results 2Q11 Net Sales of $41.2 Million 2Q11 Net Loss of $21.2 Million, or $0.37 per Diluted Share Qingdao, China and Rockville, Md. – November 4, 2010 – Synutra International, Inc. (NASDAQ: SYUT), a leading infant formula company in China and a producer, marketer and seller of nutritional products for] []
[Synutra Reports Second Quarter and First Half Fiscal 2011 Financial Results 2Q11 Net Sales of $41.2 Million 2Q11 Net Loss of $21.2 Million, or $0.37 per Diluted Share Qingdao, China and Rockville, Md. – November 4, 2010 – Synutra International, Inc. (NASDAQ: SYUT), a leading infant formula company in China and a producer, marketer and seller of nutritional products for] []
